Literature DB >> 17926235

Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).

H Hauner1, J Hanisch, P Bramlage, E Steinhagen-Thiessen, H Schunkert, K-H Jöckel, J Wasem, S Moebus.   

Abstract

AIMS: Primary care physicians are gatekeepers of the healthcare system and thus responsible for screening, prevention and treatment of diabetes. Little is known about the prevalence of diabetes, impaired fasting glucose and factors that are associated with the risk of future development of diabetes and subsequent cardiovascular disease in unselected patients presenting to general practitioners. RESEARCH DESIGN AND METHODS: A nationwide sample of 35,869 primary care patients screened in 2005 was used to estimate the prevalence of detected and undetected diabetes as well as of impaired fasting glucose. Logistic regressions were used to assess the prevalence, cardiovascular morbidity and the factors associated with undetected diabetes and impaired fasting glucose.
RESULTS: 1) Using a blood glucose screening algorithm the prevalence of known type 1 and type 2 diabetes mellitus was found to be 0.6 and 12.2%, respectively. Another 2.9% (23% of the diagnosed) had either undiagnosed diabetes (0.9%) or impaired fasting glucose (2.0%). 2) Undiagnosed patients had a more unfavourable cardiovascular risk profile compared to non-diabetic patients. 3) Moreover, higher age, male gender, low HDL-cholesterol and elevated triglycerides as well as a family history of diabetes were associated with unknown diabetes or impaired fasting glucose.
CONCLUSIONS: Approximately 15.7% of individuals in Germany consulting a primary care physician are affected from either diabetes (known and unknown) or impaired fasting glucose and face a substantially elevated cardiovascular risk score. This study demonstrated that using a simplified blood glucose screening algorithm considering risk markers like higher age, male gender, low HDL-cholesterol, high triglycerides and a family history of diabetes may well serve as a suitable screening approach for undiagnosed diabetes and impaired fasting glucose in primary care practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17926235     DOI: 10.1055/s-2007-985359

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  11 in total

Review 1.  Considering the inclusion of metabolic and cardiovascular markers in the Panel Study of Income Dynamics.

Authors:  Noreen Goldman; Jennifer B Dowd
Journal:  Biodemography Soc Biol       Date:  2009

2.  Prevalence of the metabolic syndrome in unipolar major depression.

Authors:  Kai G Kahl; Wiebke Greggersen; Ulrich Schweiger; Joachim Cordes; Chakrapani Balijepalli; Christian Lösch; Susanne Moebus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-20       Impact factor: 5.270

3.  [Medical decision making in symptoms of type 2 diabetes mellitus in general practice].

Authors:  W de Cruppé; O von dem Knesebeck; E Gerstenberger; C Link; L Marceau; J Siegrist; M Geraedts; J McKinlay
Journal:  Dtsch Med Wochenschr       Date:  2011-02-17       Impact factor: 0.628

4.  Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study.

Authors:  Susanne Moebus; Chakrapani Balijepalli; Christian Lösch; Laura Göres; Bernd von Stritzky; Peter Bramlage; Jürgen Wasem; Karl-Heinz Jöckel
Journal:  Cardiovasc Diabetol       Date:  2010-08-09       Impact factor: 9.951

5.  Regional differences in the prevalence of the metabolic syndrome in primary care practices in Germany.

Authors:  Susanne Moebus; Jens Hanisch; Peter Bramlage; Christian Lösch; Hans Hauner; Jürgen Wasem; Karl-Heinz Jöckel
Journal:  Dtsch Arztebl Int       Date:  2008-03-21       Impact factor: 5.594

Review 6.  Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction.

Authors:  Wolfgang Rathmann; Christa Scheidt-Nave; Michael Roden; Christian Herder
Journal:  Dtsch Arztebl Int       Date:  2013-05-10       Impact factor: 5.594

7.  Elevated HbA1c levels in individuals not diagnosed with type 2 diabetes in Qatar: a pilot study.

Authors:  Marjonneke J Mook-Kanamori; Mohammed M El-Din Selim; Ahmed H Takiddin; Khoulood A S Al-Mahmoud; Hala Al-Homsi; Cindy McKeon; Wadha A Al Muftah; Sara Abdul Kader; Dennis O Mook-Kanamori; Karsten Suhre
Journal:  Qatar Med J       Date:  2014-12-09

8.  Association of FV G1691A Polymorphism but not A4070G With Coronary Artery Disease.

Authors:  Ahmed Amara; Meriem Mrad; Aicha Sayeh; Abdeddayem Haggui; Dhaker Lahideb; Najiba Fekih-Mrissa; Habib Haouala; Brahim Nsiri
Journal:  Clin Appl Thromb Hemost       Date:  2017-11-27       Impact factor: 2.389

9.  Prevalence of obesity in primary care using different anthropometric measures--results of the German Metabolic and Cardiovascular Risk Project (GEMCAS).

Authors:  Hans Hauner; Peter Bramlage; Christian Lösch; Elisabeth Steinhagen-Thiessen; Heribert Schunkert; Jürgen Wasem; Karl-Heinz Jöckel; Susanne Moebus
Journal:  BMC Public Health       Date:  2008-08-11       Impact factor: 3.295

Review 10.  SGLT2 inhibitors - an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin.

Authors:  Jochen Seufert
Journal:  Diabetes Metab Syndr Obes       Date:  2015-11-09       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.